Stop by and see us at Booth #1521.

December 6, 2017 | Front Line Genomics recently interviewed Variantyx CEO Haim Neerman at the American Society of Human Genetics conference in Orlando, Florida, where they discussed why whole genome sequencing is the future of genomic diagnostic testing …

Hear Variantyx’s CSO Noam Shomron speak on big data in breast cancer at the upcoming Summit on Controversies in Precision Medicine!

Join us at the upcoming 2017 Association for Molecular Pathology (AMP) annual conference!

Join us at the upcoming 2017 American Society of Human Genetics (ASHG) annual conference!

September 13, 2017. Framingham, MA.

Variantyx today announced the launch of its proprietary Variantyx Unity™ test at the National Society of Genetic Counselors (NSGC) conference in Columbus, Ohio. Using whole genome sequenced (WGS) data analyzed by the proprietary Genomic Intelligence® platform, Variantyx Unity™ is the first genomic diagnostic test to identify small sequence changes, structural variants, trinucleotide repeat expansions and mitochondrial variants from a single DNA sample, eliminating the need for multiple sequential tests.

Join us at the Impact of Big Data Analytics conference to hear Noam Shomron, Variantyx CSO, speak about WGS and cancer predisposition.